MEDICATION GUIDE. (tocilizumab)

Similar documents
MEDICATION GUIDE XELJANZ (ZEL JANS ) (tofacitinib)

How does my new treatment work?

Medication Guide Enbrel (en-brel) (etanercept)

o Your healthcare provider should test you for TB before starting CIMZIA.

ORENCIA (oh-ren-see-ah) (abatacept)

MEDICATION GUIDE HUMIRA

What are my treatment support resources?

The ORENCIA (abatacept) JIA Observational Registry

MEDICATION GUIDE. BENLYSTA (ben-list-ah) (belimumab) Injection for intravenous use

Steps TO HELP YOU TALK WITH YOUR DOCTOR ABOUT YOUR TREATMENT OPTIONS

Actemra concentrate for intravenous infusion

(continued) MEDICATION GUIDE Rx Only KEVZARA (KEV-za-ra) (sarilumab) injection, for subcutaneous use

Specialty Pharmacies: What they are. Why they are different.

JUST FOR KIDS SELECTED IMPORTANT SAFETY INFORMATION

contains the active ingredient tocilizumab (rch) It does not contain all the available information.

KEEP UP THE FIGHT WITH. Little Victories

Get an Insurance Benefits Review for ORENCIA (abatacept)

Show your doctor how juvenile idiopathic arthritis affects your child

PATIENT INFORMATION. ORENCIA (oh-ren-see-ah) (abatacept) Lyophilized Powder for Intravenous Infusion

Olumiant (baricitinib) tablets

While every patient s experience is different, here are the general findings from clinical trials:

Tocilizumab (Actemra )

Tamala, treating her RA with ACTEMRA SC injections

Lymphoma, skin cancer, and other types of cancer have happened in people treated with this drug. Talk with your doctor.

MEDICATION GUIDE PegIntron (peg-in-tron) (Peginterferon alfa-2b) for injection, for subcutaneous use

MEDICATION GUIDE. (belatacept) For Injection, For Intravenous Use

PRESCRIBER SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR THE HEALTHCARE PROVIDER

Have a healthy discussion. Use this guide to start a. conversation. with your. healthcare provider

PATIENT SAFETY BROCHURE; IMPORTANT SAFETY INFORMATION FOR PATIENTS. Before starting on Soliris Important safety information for patients

WHAT YOU SHOULD KNOW ABOUT RoACTEMRA

Lymphoma, skin cancer, and other types of cancer have happened in people treated with this drug. Talk with your doctor.

While every patient s experience is different, here are the general findings from clinical trials:

MEDICATION GUIDE Rx Only KEVZARA (KEV-za-ra) (sarilumab) injection, for subcutaneous use What is the most important information I should know about

Before starting on Soliris.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. SYLVANT pronounced SILL-vant siltuximab for injection

Your treatment with XELJANZ

Discussing TECENTRIQ (atezolizumab) with your healthcare team Talking to Your Doctor

Patient Information IXEMPRA Kit (pronounced as ǐk-'sĕm-pră) (ixabepilone) What is the most important information I should know about IXEMPRA?

REMICADE Infliximab Consumer Medicine Information

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

GlaxoSmithKline Research Triangle Park, NC the ViiV Healthcare group of companies. All rights reserved. ZGN:XPI

FDA APPROVED MEDICATION GUIDE

Inlyta (axitinib) for Kidney Cancer

DEDICATED SUPPORT TO HELP YOU GET STARTED AND STAY ON TRACK THROUGHOUT YOUR TREATMENT

Tocilizumab Tocilizumab

Patient Information VERSACLOZ (VER sa kloz) (clozapine) Oral Suspension

Golimumab (Simponi ) Therapy

While every patient s experience is different, here are the general findings from clinical trials:

MEDICATION GUIDE SIMPONI (SIM-po-nee) (golimumab)

Dexamethasone is used to treat cancer. This drug can be given in the vein (IV), by mouth, or as an eye drop.

ORENCIA (or-en-see-ah)

acting aggressive, being angry or violent yourself, or feeling hopeless)

Medication Guide. VIDEX EC (VY-dex Ee-see) (didanosine, also known as ddi) Delayed-Release Capsules Enteric-Coated Beadlets

PART III: CONSUMER INFORMATION

FDA-approved Medication Guide MEDICATION GUIDE. RIBASPHERE (Rīb-ă-sphere) Tablets

Why have I been selected for treatment with adalimumab?

BACK FIGHT. It s time to. Take action today. Ask your rheumatologist about ORENCIA.

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PART III: PATIENT MEDICATION INFORMATION. ixekizumab

For males: use effective birth control during your treatment with INLYTA. Talk to your doctor about birth control methods.

PART III: CONSUMER INFORMATION

What You Need to Know About ARZERRA (ofatumumab)

Rheumatoid Arthritis Fact Sheet

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

Easy as knowing how to take the next step.

Tuscarawas County Health Department. Vivitrol Treatment Consent

Patient Information ALVESCO [ael- ves-koʊ] (ciclesonide) Inhalation Aerosol. Do not use your ALVESCO Inhalation Aerosol near heat or an open flame.

MEDICATION GUIDE Valproic Acid (val pro ic acid) Capsules

INSTRUCTIONS FOR USE ORENCIA (oh-ren-see-ah) (abatacept) Prefilled Syringe with BD UltraSafe Passive Needle Guard

Nivolumab. Other Names: Opdivo. About this Drug. Possible Side Effects (More Common) Warnings and Precautions

Infliximab (Remicade ) Therapy

MEDICATION GUIDE Prasugrel (pra-su-grel) tablets Read this Medication Guide before you start taking prasugrel and each time you get a refill.

YOUR INTRODUCTION TO. INFLECTRA is a trademark of Hospira UK, a Pfizer company.

Methotrexate. About This Drug. Possible Side Effects. Warnings and Precautions

Tips to Help Treat Diarrhea, Nausea, and Vomiting Side Effects

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

Patient Information Entecavir Tablets (en-tek-ah-veer)

Patient Information. Telmisartan and Hydrochlorothiazide (TEL-mi-SAR-tan and HYE-droe-KLOR-oh-THYE-a-zide) Tablets. Rx Only

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la]

MEDICATION GUIDE. Peganone 250 mg Tablets (PEG-ah-noan) (ethotoin tablets, USP)

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION

ORENCIA (or-en-see-ah)

Anti-Tumor Necrosis Factor (Anti-TNF)

MEDICATION GUIDE JANTOVEN (JAN-to-ven) Tablets (Warfarin Sodium Tablets, USP)

MEDICATION GUIDE Abacavir, Lamivudine and Zidovudine Tablets (a-bak-a-vir, la-miv-ue-deen, zye-doe-vue-deen)

XELJANZ tofacitinib (as citrate) tablet

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. [new-ka la] Mepolizumab for Injection

Acthar TREATMENT JOURNAL

Patient Information MICARDIS HCT (my-car-dis HCT) (telmisartan and hydrochlorothiazide) Tablets

What is the most important information I should know about bortezomib? What should I discuss with my healthcare provider before receiving bortezomib?

All medicines have risks and benefits. Your doctor has weighed the risks of you being given Mabthera SC against the benefits expected for you.

INFLECTRA is a trademark of Hospira UK, a Pfizer company.

If you have any concerns about using this medicine, ask your doctor or pharmacist.

Patient Information Montelukast Sodium Tablets and Montelukast Sodium Chewable Tablets

SAY HELLO TO CLEARER SKIN. SAY HELLO TO TREMFYA.

For the Patient: Rituximab injection Other names: RITUXAN

MEDICATION GUIDE. The risk of getting a serious skin rash is higher if you:

DIVALPROEX (di val pro ex) SODIUM DELAYED-RELEASE TABLETS, USP

What do I need to tell my doctor BEFORE I take this drug? If you have an allerg y to ofatumumab or any other part of this drug.

FOR PATIENTS WITH SYMPTOMS OF SARCOIDOSIS. Treatment Journal. H.P. Acthar Gel is a prescription medication used to treat symptoms of sarcoidosis.

Transcription:

MEDICATION GUIDE ACTEMRA (AC-TEM-RA) (tocilizumab) Read this Medication Guide before you start ACTEMRA and before each infusion. There may be new information. This Medication Guide does not take the place of talking with your health care provider about your medical condition or your treatment. What is the most important information I should know about ACTEMRA? ACTEMRA can cause serious side effects including: 1. Serious Infections. ACTEMRA is a medicine that affects your immune system. ACTEMRA can lower the ability of your immune system to fight infections. Some people have serious infections while taking ACTEMRA, including tuberculosis (TB), and infections caused by bacteria, fungi, or viruses that can spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting ACTEMRA Your doctor should monitor you closely for signs and symptoms of TB during treatment with ACTEMRA You should not start taki ng ACTEMRA if you have any kind of infection unless your healthcare provider says it is okay. Before starting ACTEMRA, tell your healthcare provider if you: think you have an infection or have symptoms of an infection such as: o fever, sweating, or chills o muscle aches o cough o shortness of breath o blood in phlegm o weight loss o warm, red, or painful skin or sores on your body o diarrhea or stomach pain o burning when you urinate or urinating more often than normal o feel very tired are being treated for an infection get a lot of infections or have infections that keep coming back have diabetes, HIV, or a weak immune system. People with these conditions have a higher chance for infections have TB, or have been in close contact with someone with TB live or have lived, or have traveled to certain parts of the country (such as the Ohio and Mississippi River valleys and the Southwest) where there is an increased chance for getting certain kinds of fungal infections (histoplasmosis, coccidiomycosis, or blastomycosis). These infections may happen or become more severe if you use ACTEMRA. Ask your healthcare provider, if you do not know if you have lived in an area where these infections are common have or have had hepatitis B 1

After starting ACTEMRA, call your healthcare provider right away if you have any symptoms of an infection. ACTEMRA can make you mo re likely to get infections or make worse any infection that you have. 2. Tears (perforation) of the stomach or intestines. Tell your healthcare provider if you have had diverticulitis (inflammation in parts of the large intestine) or ulcers in your stomach or intestines. Some people taking ACTEMRA get tears in their stomach or intestine. This happens most often in people who also take nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or methotrexate Tell your healthcare provider right away if you have fever and stomach-area pain that does not go away, and a change in your bowel habits 3. Changes in certain laboratory test results. Your healthcare provider should do blood tests before you start receiving ACTEMRA and every 4 to 8 weeks for rheumato id arthritis and every 2 to 4 weeks for SJIA during treatment to chec k for the following side effects of ACTEMRA: 4. Cancer. low neutrophil count. Neutrophils are white blood cells that help the body fight off bacterial infections low platelet count. Platelets are blood cells that help with blood clotting and stop bleeding increase in certain liver function tests You should not receive ACTEMRA if your neutr ophil or platelet counts are too lo w or your liver function tests are too high. Your healthcare provider may s top your ACTEMRA treatment for a period of time or change your dose of medicine if needed because of changes in these blood test results. You may a lso have changes in other laboratory tests, such as your blood cholesterol levels. Your healthcare provider should do blood tests to che ck your cholesterol levels 4 to 8 weeks after you start receiving ACTEMRA, and then every 6 months after that. Normal cholesterol levels are important to good heart health. ACTEMRA may increase your risk of certain cancers by chang ing the way your immune system works. Tell your healthcare provider if you have ever had any type of cancer. See What are the possible side effects with ACTEMRA? for more information about side effects. What is ACTEMRA? ACTEMRA is a prescription medicine called an Interleukin-6 (IL-6) receptor inhibitor. ACTEMRA is used to treat: Adults with moderately to severely active rheumatoid arthritis (RA) after at least one other medicine called a Disease Modifying Anti-Rheumatic Drug (DMARD) has been used and did not work well People with active systemic juvenile idiopathic arthritis (SJIA) ages 2 and above It is not known if ACTEMRA is safe and effective in children with SJIA under 2 years of age or in children with conditions other than SJIA. 2

Who should not take ACTEMRA? Do not take ACTEMRA if you are allergic to tocilizumab, or any of the ingredients in ACTEMRA. See the end of this Medication Guide for a complete list of ingredients in ACTEMRA. What should I tell my healthcare provider before receiving ACTEMRA? ACTEMRA may not be right for you. Before receiving ACTEMRA, tell your healthcare provider if you: have an infection. See What is the most important information I should know about ACTEMRA? have liver problems have any stomach-area (abdominal) pain or been diagnosed with diverticulitis or ulcers in your stomach or intestines have had a reaction to tocilizumab or any of the ingredients in ACTEMRA before have or had a condition that affects your nervous system, such as multiple sclerosis have recently received or are scheduled to receive a vaccine. People who take ACTEMRA should not receive live vaccines. People taking ACTEMRA can receive non-live vaccines plan to have surgery or a medical procedure have any other medical conditions plan to become pregnant or are pregnant. It is not known if ACTEMRA will harm your unborn baby Pregnancy Registry: Genentech has a registry for pregnant women who take ACTEMRA. The purpose of this registry is to check the health of the pregnant mother and her baby. If you are pregnant or become pregnant whi le taking ACTEMRA, talk to your healthcare provider about how you can joi n this pregnancy registry or you may contact the registry at 1-877-311-8972 to enroll. plan to breast-feed or are breast-feeding. You and your healthcare provider should decide if you will take ACTEMRA or breast-feed. You should not do both Tell your healthcare provider about all of the medicines you take, including prescription and non-prescription medicines, vitamins and h erbal supplements. ACTEMRA and other medicines may affect each other causing side effects. Especially tell your healthcare provider if you take: any other medicines to treat your RA. You should not take etanercept (Enbrel ), adalimumab (Humira ), infliximab (Remicade ), rituximab (Rituxan ), abatacept (Orencia ), anakinra (Kineret ), certolizumab (Cimzia ), or golimumab (Simponi ), while you are taking ACTEMRA. Taking ACTEMRA with these medicines may increase your risk of infection medicines that affect the way certain liver enzymes work. Ask your healthcare provider if you are not sure if your medicine is one of these Know the medicines you take. Keep a list of them to show to your h ealthcare provider and pharmacist when you get a new medicine. How will I receive ACTEMRA? You will receive ACTEMRA from a healthcare provider through a needle placed in a vein in your arm (IV or intravenous infusion). The infusion will take about 1 hour to give you the full dose of medicine 3

For rheumatoid arthritis you will receive a dose of ACTEMRA about every 4 weeks For SJIA you will receive a dose of ACTEMRA about every 2 weeks If you miss a scheduled dose of ACTEMRA, ask your healthcare provider when to schedule your next infusion While taking ACTEMRA, you may continue to use other medicines that help treat your rheumatoid arthritis or SJIA such as methotrexate, non-steroidal anti-inflammatory drugs (NSAIDs) and prescription steroids, as instructed by your healthcare provider Keep all of your follow-up appointments and get your blood tests as ordered by your healthcare provider What are the possible side effects with ACTEMRA? ACTEMRA can cause serious side effects, including: See What is the most important information I should know about ACTEMRA? Hepatitis B infection in people who carry the virus in their blood. If you are a carrier of the hepatitis B virus (a virus that affects the liver), the virus may become active while you use ACTEMRA. This happens with other biologic medicines used to treat RA. Your doctor may do blood tests before you start treatment with ACTEMRA and while you are using ACTEMRA. Tell your healthcare provider if you have any of the following symptoms of a possible hepatitis B infection: o feel very tired o skin or eyes look yellow o little or no appetite o vomiting o clay-colored bowel movements o fevers o chills o stomach discomfort o muscle aches o dark urine o skin rash Serious Allergic Reactions. Serious allergic reactions, including death, can happen with ACTEMRA. These reactions can happen with any infusion of ACTEMRA, even if they did not occur with an earlier infusion. Tell your healthcare provider right away if you have any of the following signs of a serious allergic reaction: o shortness of breath or trouble breathing o skin rash o swelling of the lips, tongue, or face o chest pain o feeling dizzy or faint Nervous system problems. Multiple Sclerosis has been diagnosed rarely in people who take ACTEMRA. It is not known what effect ACTEMRA may have on some nervous system disorders Common side effects of ACTEMRA include: upper respiratory tract infections (common cold, sinus infections) headache increased blood pressure (hypertension) 4

Tell your healthcare provider if you have any s ide effect that bothers you or that does not go away. These are not all of the possible side effects of ACTEMRA. For more i nformation, ask your healthcare provider or pharmacist. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Genentech at 1-888-835-2555. General information about ACTEMRA. Medicines are sometimes prescribed for purposes other than those li sted in a Medication Guide. This Medication Guide summarizes the most important information about ACTEMRA. If you wo uld like more information, talk to your healthcare provider. You can ask your pharmacist or healthc are provider for information about ACT EMRA that i s written for heal th professionals. For more information, go to www.actemra.com or call 1-800-ACTEMRA. What are the ingredients in ACTEMRA? Active ingredient: tocilizumab Inactive ingredients: sucrose, polysorbate 80, disodium phosphate dodecahydrate, sodium dihydrogen phosphate dihydrate. This Medication Guide has been approved by the U.S. Food and Drug Administration. MG Revised: October 2012 ACTEMRA is a registered trademark of Chugai Seiyaku Kabushiki Kaisha Corp., a member of the Roche Group. 2012 Genentech, Inc. All rights reserved. 5